Sirio Pharma Co., Ltd. (SHE:300791)

China flag China · Delayed Price · Currency is CNY
20.55
-0.47 (-2.24%)
Mar 9, 2026, 3:04 PM CST
-0.69%
Market Cap 6.29B
Revenue (ttm) 4.45B
Net Income (ttm) 345.53M
Shares Out 305.96M
EPS (ttm) 1.13
PE Ratio 18.15
Forward PE 22.90
Dividend 0.50 (2.38%)
Ex-Dividend Date May 27, 2025
Volume 2,187,528
Average Volume 3,148,646
Open 20.87
Previous Close 21.02
Day's Range 20.32 - 20.94
52-Week Range 16.32 - 28.19
Beta 0.31
RSI 28.93
Earnings Date Apr 24, 2026

About Sirio Pharma

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China. [Read more]

Industry Packaged Foods
Founded 1993
Employees 2,776
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300791
Full Company Profile

Financial Performance

In 2024, Sirio Pharma's revenue was 4.21 billion, an increase of 17.56% compared to the previous year's 3.58 billion. Earnings were 325.06 million, an increase of 15.66%.

Financial Statements

News

There is no news available yet.